The Efficacy and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia

This study has been completed.

Study NCT00034749 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

First Received: May 2, 2002 Last Updated: October 16, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	March 2006
Estimated Primary Completion Date:	No date given